The immediate investment discussion centres on digital mental health service contracts and user engagement. This theme is relevant to Kooth PLC because it influences how investors assess futureEarningsquality,Capitalneeds and the durability of its commercial proposition. A topic attracting attention does not by itself establish …
The immediate investment discussion centres on therapeutics development and commercial milestones. This theme is relevant to CRISM Therapeutics Corporation because it influences how investors assess futureEarningsquality,Capitalneeds and the durability of its commercial proposition. A topic attracting attention does not by itself establish a share-price …
The immediate investment discussion centres on life-sciences commercial development and customer demand. This theme is relevant to Eden Biosolutions PLC because it influences how investors assess futureEarningsquality,Capitalneeds and the durability of its commercial proposition. A topic attracting attention does not by itself establish a …
The immediate investment discussion centres on diagnostic manufacturing demand and operational efficiency. This theme is relevant to EKF Diagnostics Holdings plc because it influences how investors assess futureEarningsquality,Capitalneeds and the durability of its commercial proposition. A topic attracting attention does not by itself establish …
For the six months to 30 June 2026, revenue fell 5% to £24.0m from £25.2m, according to the results. Clinical revenue, from sales of devices and tests to healthcare providers, rose 3% to £20.6m.Clinical Trialsrevenue, generated mainly from pharmaceutical companies using the devices in …
The board said its expectations for the 2026 financial year were unchanged, and that it expected revenue and adjusted EBITDA growth in line with market expectations. The company cited consensus forecasts of £54.6m of revenue and £13.6m of adjusted EBITDA. On our arithmetic, meeting …
The development most relevant to deliverability in recent weeks has come from the bidder's side. On 8 October 2026, H.B. Fuller said it had priced US$850m of senior unsecured notes due 2034, carrying a coupon of 7.625% and issued at 100% of principal, with …
According to the July announcement, the company said its incident response plan had been activated, the board had appointed external cyber security and forensic specialists, and the incident had been contained. External specialists reportedly confirmed no residual indicators of compromise, and the company said …
• Japan's Ministry of Health, Labour and Welfare accepts a New Drug Application for the same lung cancer combination.
• It is the company's second Phase 3 Huntington's disease award in the past 12 months.